Jun 19, 2026 02:00AM
Jun 15, 2026 09:24AM
Jun 14, 2026 04:35PM
Jun 14, 2026 04:35PM
Jun 13, 2026 06:01AM
Jun 13, 2026 06:00AM
Jun 8, 2026 07:00AM Incyte to acquire Vega Therapeutics for $1.25 billion upfront
Jun 8, 2026 07:00AM
Jun 4, 2026 08:06AM
Jun 4, 2026 08:05AM
Jun 1, 2026 02:53AM
May 30, 2026 08:00AM
May 12, 2026 09:30AM
May 7, 2026 08:50AM Incyte reports 24-week data for Opzelura cream in moderate atopic dermatitis
May 7, 2026 08:50AM
May 3, 2026 12:00PM
May 1, 2026 05:28PM
May 1, 2026 05:28PM
Apr 29, 2026 10:15AM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM Incyte Appoints Suketu (Suky) Upadhyay as Chief Financial Officer
Apr 28, 2026 07:00AM
Apr 23, 2026 05:48AM
Apr 23, 2026 03:00AM
Apr 21, 2026 10:00AM
Apr 21, 2026 10:00AM
Apr 7, 2026 12:26PM
Apr 7, 2026 07:30AM Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Apr 2, 2026 07:01AM
Apr 2, 2026 07:01AM
Mar 30, 2026 10:19AM
Mar 30, 2026 04:21AM
Mar 28, 2026 03:00PM
Mar 25, 2026 09:13AM
Mar 24, 2026 04:02PM Barclays reiterates Overweight on Incyte (INCY) despite mixed Ph3 trial results
Mar 20, 2026 10:00AM
Mar 17, 2026 07:30AM
Mar 17, 2026 07:30AM
Mar 9, 2026 08:00AM
Feb 27, 2026 08:13AM
Feb 27, 2026 08:11AM
Feb 19, 2026 05:31PM Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
Feb 17, 2026 10:48AM
Feb 16, 2026 05:31PM
Feb 10, 2026 07:00AM
Jan 30, 2026 09:29AM
Jan 30, 2026 09:29AM
Jan 5, 2026 01:33PM
Jan 5, 2026 07:30AM Incyte drug trial meets primary endpoint for lymphoma treatment
Jan 5, 2026 07:30AM

324,023 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All